SG

Sophie Gleizes

USP Developpement Scientist In Phagotherapy at Clean Cells

Sophie Gleizes is a bioprocess engineer at Naobios since January 2022, specializing in the design and optimization of virus development and manufacturing processes for clinical trials, adhering to BPF guidelines. Concurrently, Sophie serves as a USP development scientist in phagotherapy at Clean Cells, focusing on laboratory establishment, bacterial culture optimization, and technology transfer documentation. Prior experience includes positions as an upstream process development scientist at Merck Life Science, where cell culture operations were optimized, and as a USP research officer at Glenmark Pharmaceuticals, specializing in monoclonal antibody process development. Sophie's background includes a significant internship at Glenmark Pharmaceuticals involving mammalian cell culture process characterization, and earlier work in establishing a stable CHO cell line producing erythropoietin. Education credentials include a Master's degree in biotechnologies from ENSTBB Bordeaux INP and preparatory studies in biology, chemistry, physics, and mathematics.

Location

Bordeaux, France

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


Clean Cells

Clean Cells offers a comprehensive service portfolio ranging from test for viral and biological safety of biopharmaceuticals, the production of cell and virus banks that are GMP grade and secure storage, as well as the production of experimental drugs such as cell therapy products and therapeutic phages. Clean Cells aims to become a major role inthe development of new therapies to revolutionize personalized medicine.


Headquarters

Boufféré, France

Employees

51-200

Links